BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36042349)

  • 21. Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration.
    Wang Y; Liu F; Mao F; Hang Q; Huang X; He S; Wang Y; Cheng C; Wang H; Xu G; Zhang T; Shen A
    J Biol Chem; 2013 Mar; 288(13):9028-34. PubMed ID: 23393140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists.
    Liu F; Jiang W; Sui Y; Meng W; Hou L; Li T; Li M; Zhang L; Mo J; Wang J; Zhao Y; Zhang L; Ma J; Tang Y
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12986-12995. PubMed ID: 31182587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters.
    Webb BM; Bryson BL; Williams-Medina E; Bobbitt JR; Seachrist DD; Anstine LJ; Keri RA
    J Biol Chem; 2021 Oct; 297(4):101162. PubMed ID: 34481843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer.
    Kim J; Cho YJ; Ryu JY; Hwang I; Han HD; Ahn HJ; Kim WY; Cho H; Chung JY; Hewitt SM; Kim JH; Kim BG; Bae DS; Choi CH; Lee JW
    Gynecol Oncol; 2020 Jan; 156(1):211-221. PubMed ID: 31776040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GRP78 inhibition enhances ATF4-induced cell death by the deubiquitination and stabilization of CHOP in human osteosarcoma.
    Luo J; Xia Y; Luo J; Li J; Zhang C; Zhang H; Ma T; Yang L; Kong L
    Cancer Lett; 2017 Dec; 410():112-123. PubMed ID: 28947141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.
    Hur JY; Kim HR; Lee JY; Park S; Hwang JA; Kim WS; Yoon S; Choi CM; Rho JK; Lee JC
    Cell Oncol (Dordr); 2019 Aug; 42(4):449-458. PubMed ID: 30838525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin-dependent kinase 7 inhibitors in cancer therapy.
    Wang M; Wang T; Zhang X; Wu X; Jiang S
    Future Med Chem; 2020 May; 12(9):813-833. PubMed ID: 32208930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing.
    Nilson KA; Guo J; Turek ME; Brogie JE; Delaney E; Luse DS; Price DH
    Mol Cell; 2015 Aug; 59(4):576-87. PubMed ID: 26257281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of CDK7 substrate specificity by MAT1 and TFIIH.
    Yankulov KY; Bentley DL
    EMBO J; 1997 Apr; 16(7):1638-46. PubMed ID: 9130709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canine osteosarcoma cells exhibit basal accumulation of multiple chaperone proteins and are sensitive to small molecule inhibitors of GRP78 and heat shock protein function.
    Mattos DR; Weinman MA; Wan X; Goodall CP; Serrill JD; McPhail KL; Milovancev M; Bracha S; Ishmael JE
    Cell Stress Chaperones; 2022 May; 27(3):223-239. PubMed ID: 35244890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cdk7: a kinase at the core of transcription and in the crosshairs of cancer drug discovery.
    Fisher RP
    Transcription; 2019 Apr; 10(2):47-56. PubMed ID: 30488763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomaterial-Facilitated Cyclin-Dependent Kinase 7 Inhibition Suppresses Gallbladder Cancer Progression via Targeting Transcriptional Addiction.
    Huang CS; Xu QC; Dai C; Wang L; Tien YC; Li F; Su Q; Huang XT; Wu J; Zhao W; Yin XY
    ACS Nano; 2021 Sep; 15(9):14744-14755. PubMed ID: 34405985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrative multi-omics approach uncovers the regulatory role of CDK7 and CDK4 in autophagy activation induced by silica nanoparticles.
    Ruan C; Wang C; Gong X; Zhang Y; Deng W; Zhou J; Huang D; Wang Z; Zhang Q; Guo A; Lu J; Gao J; Peng D; Xue Y
    Autophagy; 2021 Jun; 17(6):1426-1447. PubMed ID: 32397800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of TNF-α/NF-κB axis enhances CRL4B
    Zhang C; Chen B; Jiang K; Lao L; Shen H; Chen Z
    Mol Oncol; 2018 Apr; 12(4):476-494. PubMed ID: 29377600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for CDK7 activation by MAT1 and Cyclin H.
    Peissert S; Schlosser A; Kendel R; Kuper J; Kisker C
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26739-26748. PubMed ID: 33055219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kuanoniamine C stimulates bortezomib-induced cell death via suppression of glucose-regulated protein 78 in osteosarcoma.
    Machihara K; Namba T
    Biochem Biophys Res Commun; 2020 Jun; 527(1):289-296. PubMed ID: 32446382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of CDK7 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis.
    Wang Q; Li M; Zhang X; Huang H; Huang J; Ke J; Ding H; Xiao J; Shan X; Liu Q; Bao B; Yang L
    Exp Mol Pathol; 2016 Jun; 100(3):514-21. PubMed ID: 27155449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle Phenotype.
    Olson CM; Liang Y; Leggett A; Park WD; Li L; Mills CE; Elsarrag SZ; Ficarro SB; Zhang T; Düster R; Geyer M; Sim T; Marto JA; Sorger PK; Westover KD; Lin CY; Kwiatkowski N; Gray NS
    Cell Chem Biol; 2019 Jun; 26(6):792-803.e10. PubMed ID: 30905681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma.
    Chen HD; Huang CS; Xu QC; Li F; Huang XT; Wang JQ; Li SJ; Zhao W; Yin XY
    Int J Biol Sci; 2020; 16(7):1207-1217. PubMed ID: 32174795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAT1, cdk7 and cyclin H form a kinase complex which is UV light-sensitive upon association with TFIIH.
    Adamczewski JP; Rossignol M; Tassan JP; Nigg EA; Moncollin V; Egly JM
    EMBO J; 1996 Apr; 15(8):1877-84. PubMed ID: 8617234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.